Petraeus Says Iran May Be Blinking Over Strait of Hormuz Opening Door for Peace Deal SpaceX and OpenAI Public Debuts Could Surpass Berkshire Hathaways Market Value on First Trading Day US Productivity Growth Decelerates Unit Labor Costs Accelerate in Q4 Meta Reduces Workforce by 8000 as Company Shifts Focus to Artificial Intelligence Walmart Warns of Consumer Spending Slowdown as Rising Gas Prices Squeeze Household Budgets Deutsche Bank Raises UBS Group Price Target Maintains Buy Rating Cricut Inc CRCT Q1 2026 Earnings EPS Surges Past Estimates by 1451 Two Harbors Investment Corp Q1 2026 Earnings Strong EPS Beat Amid Stable Interest Rate Environment LSBK Q3 2025 Earnings Steady Profitability Amidst Stable Operations MRT Q4 2025 Earnings Narrower Loss Surprises Market Stock Slightly Dips Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns Bed Bath Beyond Inc BBBY Q1 2026 Earnings NarrowerthanExpected Loss Reported Amid Restructuring Uncertainty John Hancock Preferred Income Fund HPI Shows Resilience with Modest Uptick Near Support Aldel Financial II Inc Units ALDFU Edges Higher as Price Nears Resistance Level Healthcare Services Group HCSG Climbs 135 as Stock Nears Resistance Zone Banco De Chile ADS Holds Steady Near 3878 as Key Levels Remain in Focus Tantech Holdings TANH Stock Holds Steady at 042 Key Levels in Focus Cohen Steers Inc CNS Holds Steady Near Support Amid Modest Decline Under Armour UAA Rallies 38 as Shares Test Key Resistance Levels Logitech International LOGI Surges 646 Bulls Test Key Resistance Zone PDF Solutions PDFS Gains 621 as Semiconductor Analytics Demand Drives Momentum Opus Genetics IRD Hovers Near Support After Modest Decline ARKO Corp Holds Near Support Amid Modest Uptick Companies Continue Betting on Prediction Markets Amid Regulatory Uncertainty GFS Q1 2026 Earnings EPS Surges Past Estimates Amid Sharp Stock Decline CBIZ Inc CBZ Rises 149 as Stock Tests Resistance Near 3352 Compass Inc Q1 2026 Earnings Beats EPS Estimates by Wide Margin Stock Edges Lower Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment TECX Q1 2026 Earnings Loss Widens but Pipeline Optimism Drives Stock Higher DSGN Q1 2026 Earnings EPS Beats Estimates as Development Stage Biotech Advances Pipeline EIKN Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates Stock Slips Ares Management ARES Q1 2026 Earnings EPS Misses Street View but Stock Gains on Resilient Business Trends POWL Q1 2026 Earnings EPS Misses Estimates by Nearly 10